GOLDMAN SACHS GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol: RYTM
Shares outstanding: 60,631,064 shares
Disclosed Ownership: 1,818,932 shares
Ownership: 3%
Form type: SCHEDULE 13G/A
Filing time: 10 Feb 2025, 17:30:28 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	3%	1,818,931	0	1,818,786	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	3%	1,818,931	0	1,818,786	Name: Sam Prashanth	Attorney-in-fact